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1. Introduction 
Cerebrovascular disease is the second cause of death and the most frequent cause of non-
traumatic disability in adults worldwide, according to the World Health Organization 
(WHO, 2005). Noteworthy, acute ischemic stroke accounts for about 85% of all cases (Diez-
Tejedor et al., 2001). The most common cause of stroke is a sudden occlusion of a blood 
vessel, resulting in activation of a series of biochemical events eventually leading to 
neuronal death (Dirgnal et al., 1999). Although return of blood flow (reperfusion) in 
ischemic brain tissue is essential for restoring normal function, paradoxically it can result in 
a secondary damage, where oxidative stress mediators play a critical role (Wong & Crack, 
2008).  
Antioxidant therapies have been used to determine whether oxidative stress may constitute 
a valuable therapeutic target in cerebral ischemia. Indeed, free radical scavengers (direct 
antioxidants) and agents that decrease free radicals production reduce damage in 
experimental models of cerebral ischemia. Despite experimental evidence supports the 
concept that free radicals production represents a valuable therapeutic target in stroke, 
negative results have been obtained in a number of clinical trials when some direct 
antioxidant agents have been evaluated (Aguilera et al., 2007). At present, this discrepancy 
is unclear; however, administration of treatment outside the temporal window of efficacy 
and difficulties in the establishment of the onset of ischemia and reperfusion in humans 
(Hsu et al., 2000) are factors that likely contributing to these differences. Clearly, 
development of preclinical testing must consider these factors in order to improve 
successful transition to clinical studies. 
NF-E2-Related Factor-2 (Nrf2) is a transcription factor that play a crucial role in the cellular 
protection against oxidative stress. Nrf2 is referred to as the "master regulator" of the 
antioxidant response due to the fact that it modulates the expression of several genes 
including phase 2 and antioxidant enzymes playing an important role in detoxification of 
reactive oxygen species (ROS) and electrophilic species, including heme oxygenase-1, 
NAD(P)H:quinone oxidoreductase, glutathione-S-transferase, gamma-glutamyl cysteine 
ligase, glutathione reductase, etc. Recent studies demonstrate that dysfunction of Nrf2-
driven pathways impairs cellular redox state thus oxidative stress. 
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Since ischemia and reperfusion insults generate an oxidative stress state, and considering 
that up to date there is no effective treatment to reverse morphological and behavioral 
alterations induced by stroke, it is conceivable that administration of antioxidants may limit 
oxidative damage and ameliorate progression of the disease. In this context, Nrf2 inducers 
are promising indirect antioxidant agents that are effective to attenuate oxidative stress and 
tissue/cell damage in different in vivo and in vitro experimental paradigms; therefore, here 
we review some compounds capable of inducing cellular antioxidant responses in order to 
understand their usefulness in prevention and treatment of cerebral ischemia-induced 
damage through activation of the Nrf2/ARE pathway. 
2. Mechanism related to cerebral ischemic damage 
Brain tissue requires high and constant supply of oxygen and glucose provided for the 
vascular system to maintain its viability and normal functions. Vascular obstruction – 
either transitory or permanent - of cerebral blood flow (ischemia) is accompanied by an 
immediate drop in neurological activity ultimately leading to cell death. The brain is not 
affected homogeneously and so, cerebral ischemia generates differentially damaged areas. 
Complete loss of blood flow produces an infarct zone where necrotic cell death is observed. 
The infarct area is surrounded by a penumbra zone, which is located between the infarct 
zone and the non-damaged area, or normally irrigated tissue. Cells belonging to the 
penumbra zone are still irrigated by collateral arteries, which maintain them viable for a 
variable period of time, although not functional (Figure 1). This is the area that shall be 
rescued, and the potential target for intervention with neuroprotective treatments 
(Dirgnal et al., 1999).  
The return of blood flow (reperfusion) is associated with a decrease in the infarct size and 
clinical outcome. Although reperfusion is determinant for cell function recovery, after 
prolonged periods of ischemia, it also exerts negative side-effects. If blood flow is not 
restored within hours, the penumbra region will become part of the infarct zone. In some 
patients, reperfusion may exacerbate brain injury (e.g., some patients show edema or 
intracranial hemorrhage) (Kuroda & Siesjo, 1997). In animal models, reperfusion can induce 
larger infarct areas that can be associated with permanent vessel occlusion (Aronowski et al., 
1997). 
The reduction and return of blood flow triggers a cascade of events further leading to 
neuronal death (Dirgnal et al., 1999; Durukan & Tatlisumak, 2007). Such sequence 
includes:  
1. Energy failure. This is the first event of the ischemic cascade. Cells need oxygen and 
glucose to undergo oxidative phosphorylation for energy production, consequently 
during ischemia ATP production is decreased (Figure 2). 
2. Depolarization of membrane. The impairment of ATP production disrupts Na+/K+-
ATPase and Ca2+/H+-ATPase pumps and reverses the Na+/Ca2+-transporter. Upon 
these conditions, cells are unable to maintain membrane potential and Ca2+ voltage-
dependent channels are activated, leading to depolarization of cellular membrane 
(Figure 3). 
3. Excitotoxicity and increase in intracellular Ca2+ levels. After depolarization, excitotoxic 
amino acids - mostly glutamate - are released to the synaptic cleft. Glutamate activates 
N-methyl-D-aspartic acid (NMDA), ┙-amino-3-hydroxy-5-methylisoxazole-4-propionic 
acid (AMPA), and metabotropic glutamate receptors, thereby increasing intracellular 
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Ca2+ levels. In turn, voltage gated Ca2+ channels together with reverse operation of the 
Na+/Ca2+ exchanger also increase intracellular Ca2+ levels (Figure 3). Once in the 
cytoplasmic domain, Ca2+ activates a variety of Ca2+ dependent enzymes, including 
protein kinase C, phospholipase A2, phospholipase C, cyclooxygenase-2, Ca2+-
dependent nitric oxide synthase, proteases and endonucleases, hence triggering protein 
phosphorylation, proteolysis, and mitochondrial damage. 
 
 
Fig. 1. Vascular obstruction of cerebral blood flow (ischemia) is accompanied by an 
immediate drop in neurological activity ultimately leading to cell death (infarct zone). Infarct 
core is surrounded by an area supplied with oxygen and glucose by collateral blood vessels 
(penumbra zone). Cells from the penumbra area are not functional; however, they remain 
viable for a variable period of time.  
4. Generation of free radicals and oxidative stress. Reactive oxygen (ROS) and nitrogen (RNS) 
species generation is increased during ischemia, but particularly during reperfusion, 
and they eventually lead to oxidative stress. ROS and RNS cause lipid peroxidation, 
membrane injury, disruption of cellular processes, and DNA damage. Moreover, 
oxidative stress contributes to the disruption of the blood-brain barrier, hence allowing 
the infiltration of neutrophils and other cells (see below) (Chan, 2001). 
5. Inflammation and apoptosis. Cerebral injury is a potent triggering of inflammatory 
cytokines and proteases secretion by microglia, leukocytes and resident cells of the 
neurovascular unit. Once the neurovascular barriers are breached, multiple 
neuroinflammatory cascades are activated, further leading to secondary brain injury 
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(Danton & Dietrich, 2003). Post-ischemic inflammation contributes to brain injury and 
has been linked to apoptosis. Cell death in cerebral ischemia is mainly dependent of the 
localization of the cells. For instance, in the core region, cell death is caused mainly by 
necrosis, while apoptosis predominates in the penumbra area.  
 
ISCHEMIA 
 
Fig. 2. The reduction of blood flow decreases oxygen and glucose levels; consequently, ATP 
production (Energy failure) (), glycolysis() and ATP-dependent processes are blocked. 
Upon these conditions, oxidative damage is generated by residual oxygen in mitochondria. 
Pathways that are inhibited during ischemia are crossed out in the image. TCA cycle, 
tricarboxylic acid cycle; nNOS, neuronal nitric oxide synthase. 
3. Oxidative stress is one of the most important events in 
ischemia/reperfusion-induced cerebral damage  
In cells, the predominant ROS and RNS produced are superoxide anion (O2–), hydrogen 
peroxide (H2O2), hydroxyl radical (OH), nitric oxide (NO), peroxynitrite anion (ONOO–), 
and nitrogen dioxide (NO2). In normal conditions, natural defense against ROS and RNS is 
provided by antioxidant molecules such as glutathione (GSH), ascorbic acid, ┙-tocopherol, 
and a number of antioxidant enzymes, including superoxide dismutase (SOD), glutathione 
peroxidase (GPx), and catalase (CAT). SOD converts O2– to H2O2, whereas GPx and CAT 
convert H2O2 to H2O. However, an imbalance in the formation and clearance of ROS and 
RNS can lead to oxidative stress and subsequent changes affecting the cell dynamics 
(Aguilera et al., 2007; Margaill et al., 2005). 
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Fig. 3. Reduction of blood flow decreases ATP production, disrupts ATP-dependent pumps 
() and reverses the Na+/Ca2+ transporter (). Upon these conditions, cells are unable to 
maintain membrane potential (Depolarization of membrane). After depolarization, glutamate 
(GLUT) is released and activates N-methyl-D-aspartic acid (NMDAr) and ┙-amino-3-
hydroxy-5-methylisoxazole-4-propionic acid (AMPAr) receptors(, Excitotoxicity), hence 
directly increasing intracellular Ca2+ levels (). On one hand, GLUT activates metabotropic 
glutamate receptors (mGLUr) (), which releases inositol 1,4,5-triphosphate (IP3), a 
molecule that binds to its receptor at the endoplasmatic reticulum to release more Ca2+ (, 
Increase of intracellular Ca2+ level). On the other hand, voltage gated Ca2+ channels (VDCC) 
and the reverse operation of the Na+/Ca2+-exchanger increase intracellular Ca2+ levels. 
Energy disruption also affects astrocytes, causing a deficient activity of glutamate 
transporters (EAAT1 and EAAT2) ().  
ROS and RNS produce cellular damage through lipid peroxidation, nucleic acid alteration 
and inactivation of enzymes (Figure 4); they also modify cellular signaling and gene 
regulation, contributing to breakdown of the blood-brain barrier and edema generation 
(Moro et al., 2005). Oxidative stress can ultimately induce neuronal damage, leading to 
neuronal death by apoptosis or necrosis (Loh et al., 2006).  
The brain is particularly sensitive to oxidative stress since 20% of the total oxygen consumed 
by the body is used by this organ, which constitutes only 2% of the total body weight. This 
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feature makes the brain the major generator of ROS and RNS when compared with other 
organs (Dringen, 2000). Moreover, in brain there are numerous conditions favoring ROS and 
RNS production, including: 1) a high unsaturated lipid content, 2) chemical reactions 
involving dopamine oxidation (Heiss, 2002; Hou & MacManus, 2002), 3) high concentrations 
of iron in various regions, and 4) lower antioxidant systems than other organs such as 
kidney or liver (Dringen, 2000). 
As previously described, physiopathological mechanisms leading to neuronal injury in 
cerebral stroke are complex and multifactorial. However, several studies suggest that 
oxidative stress, secondary to ROS and RNS production, actively participates during post-
ischemic brain damage (Peters et al., 1998; Rodrigo et al., 2005). During ischemia, free radical 
production in the infarct zone decreases or remains without change, while it increases 
during reperfusion. However, free radical production in the penumbral zone increases 
during both events (Liu et al., 2003). Despite the low oxygen tension produced during 
ischemia, exist an increase in ROS formation after 1.6 h of ischemia, the highest ROS 
production (489 ± 330% of control) occurs after 20 min of reperfusion, and remains increased 
at least for 3 h (Peters et al., 1998). Christensen et al. (1994) reported that ROS production is 
maximal during the first hour of reperfusion.  
Main sources of ROS, RNS, and free radicals during reperfusion are summarized as follows 
(Aguilera et al., 2007; Margaill et al., 2005):  
1. Mitochondrial respiratory chain generates O2–.  
2. Xanthine oxidase produces O2– when it catalyzes oxidation of hypoxhantine to uric 
acid.  
3. Cyclooxygenase 2 (COX-2) produces O2– during oxidative metabolism of arachidonic 
acid, a delayed process in ischemia reperfusion.  
4. NADPH oxidase (NOX) produces O2– during NADPH oxidation. 
5. Nitric oxide synthases (NOS) produce NO in normal conditions. NO produced can 
react with O2– and generate the strong oxidant ONOO–. Tetrahydrobiopterin (BH4) is 
an important regulator of NOS function because it is required to maintain enzymatic 
coupling. Loss or oxidation of BH4 to 7,8-dihydrobiopterin (BH2) is associated with 
NOS uncoupling, resulting in the production of O2– rather than NO (Crabtree & 
Channon, 2011) (Figure 4). 
4. Direct and indirect antioxidants 
Living systems have developed multiple lines of defense against oxidative stress. Cellular 
protection against oxidative stress is a process more complex than cellular protection against 
electrophiles. In this process two types of molecules participate (Dinkova-Kostova et al., 2007): 
1. Direct antioxidants. Compounds of low molecular weight (ascorbate, glutathione, 
tocopherols, lipoid acid, ubiquinones, carotenes) that can undergo redox reactions and 
scavenge reactive oxidation products (peroxides), as well as ROS and RNS (OH, ONOO–
). Direct antioxidants are consumed or modified in the process of their antioxidant action 
(ROS scavenger). Thus, it is necessary to replenish or regenerate them.  
2. Indirect antioxidants. These agents may or may not have redox activity, and exert many 
of their effects through upregulation of phase 2 and antioxidant enzymes. In turn, 
theses enzymes act catalytically, exhibit long half-lives, and display a wide variety of 
antioxidant activities, in addition to their capacities to detoxify electrophiles.  
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Fig. 4. Main sources of superoxide anion (O2–) during reperfusion are summarized as 
follows: mitochondrial respiratory chain ; cyclooxygenase-2 (COX-2) ; NADPH oxidase 
(NOX) ; xanthine oxidase (XO) ; and nitric oxide synthase (NOS), responsible for nitric 
oxide (NO) formation , or O2– if tetrahydrobiopterin (BH4) is deficient . O2– can react 
with NO to generate peroxynytrite anion (ONOO–) , or be degraded by superoxide 
dismutase (SOD) to hydrogen peroxide (H2O2) . Then, H2O2 can be catabolized by 
glutathione peroxidase (GPx) or catalase (CAT) to H2O , or react with Fe2+ to form 
hydroxyl radicals (OH) via the Fenton reaction . ONOO– can be degraded to nitrogen 
dioxide radical (NO2) and OH (11), responsible for damaging lipids, proteins and DNA. 
However, the distinction between direct and indirect antioxidants is complicated by a close 
reciprocal relation between these two types of agents, as is showed in the following 
examples (Dinkova-Kostova et al., 2007):  
1. Whilst glutathione is the main protective direct antioxidant present in high 
concentrations (mM) in tissues, its rate of synthesis is controlled by -glutamate cysteine 
ligase (GCL), a typical phase 2 enzyme that is upregulated by phase 2 inducers which 
are, by definition, indirect antioxidants. The complexity of this reciprocal relation is 
further enhanced by the mandatory participation of glutathione in activities of several 
antioxidant enzymes (glutathione peroxidase, glutathione-S-transferases, glutathione 
reductase).  
2. At least one phase 2 enzyme, heme oxygenase-1 (HO-1) generates carbon monoxide and 
biliverdin/biliruvin, which are small direct antioxidant molecules.  
3. Some direct antioxidants are inducers of the phase 2 response; e.g., the vicinal dithiol 
lipoic acid and reduced Michale reaction acceptors such as hydroquinones.  
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4. Phase 2 enzymes NADPH:quinone oxidoreductase-1 (NQO1) and glutathione reductase 
are responsible for regeneration of reduced and active forms of oxidized tocopherols, 
and ubiquinone and glutathione, respectively. 
5. Indirect antioxidants induce a cytoprotective phase 2 response 
Aerobic cells have developed an elaborated mechanism for their protection against 
oxidative stress, known as "phase 2 response" (Dinkova-Kostova & Talaly, 2008; Kensler et 
al., 2007; Kobayashi & Yamamoto, 2006; Motohashi & Yamamoto, 2004). Phase 2 response 
involves a group of genes that are regulated by a common molecular signaling pathway 
depending of the transcription factor Nrf2, and can be coordinately induced by a variety of 
synthetic and natural agents (Dinkova-Kostova et al., 2005a; Talalay, 2000). Extensive 
studies on chemistry of inducers have disclosed that all are chemically reactive without 
having common structural features (Dinkova-Kostova et al., 2004), and all react with 
sulfhydryl groups (Dinkova-Kostova et al., 2001) of highly reactive cysteine residues of 
Keap1, the cellular sensor that is integrally involved in the mechanism of induction (Itoh et 
al., 2003; Wakabayashi et al., 2004). The known inducers belong to at least nine chemical 
classes (Dinkova-Kostova et al., 2004): (i) diphenols, phenylenediamines and quinones; (ii) 
Michael reaction acceptors; (iii) isothiocyanates/dithiocarbamates; (iv) 1,2-dithiole-3-
thiones/oxathiolene oxides; (v) hydroperoxides; (vi) trivalent arsenicals; (vii) heavy metals; 
(viii) vicinal dimercaptans; and (ix) carotenoids. 
It is now widely recognized that the up-regulation of the phase 2 response is a powerful, 
highly efficient and promising strategy for protection against several diseases including 
ischemic stroke (Alfieri et al., 2011; Talalay, 2000). Experimental evidence shows the 
powerful protective effects of phase 2 response: (i) its up-regulation protects cells, animals, 
and humans against a wide variety of damaging agents including ROS, RNS, carcinogens, 
electrophiles, and radiation (Kensler et al., 2007; Kobayashi & Yamamoto, 2006; Motohashi 
& Yamamoto, 2004; Talalay et al., 2007); (ii) when the phase 2 response is disrupted, cells are 
much more susceptible to oxidative damage; and (iii) numerous anticarcinogens have been 
identified and isolated from natural sources by bioassays that monitor induction of Nrf2-
dependent enzymes such as NAD(P)H:quinone oxidoreductase (NQO1) (Kang & Pezzuto, 
2004; Zhang et al., 1992). 
5.1 Phase 2 proteins and enzymes 
In the past, enzymatic protection against oxidants focused largely on classical enzymes such 
as SOD, CAT, and various types of peroxidases (Halliwell & Gutteridge, 1999), now this is 
changing. Phase 2 proteins were originally perceived as only promoters of xenobiotic 
conjugation with endogenous ligands (e.g., glutathione, glucuronic acid) to generate more 
water-soluble and easily excretable products. This restricted view of the nature and 
functions of phase 2 proteins and enzymes has gradually been expanded. Nowadays, 
several genes are considered part of the phase 2 response. Enzymes encoded by these genes 
have chemically versatile antioxidant properties, share common regulatory mechanisms, 
and are highly inducible by a variety of agents including dietary components (Ramos-
Gomez et al., 2001; Talalay, 2000). 
Phase 2 proteins catalyze diverse reactions that collectively result in broad protection 
against the continuous damaging effects of ROS, RNS and electrophiles. They are expressed 
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at low basal levels, but can be markedly elevated by various small molecules (indirect 
antioxidants).  
Using an oligonucleotide microarray analysis, Lee et al. (2003a) reported that tert-
butylhydroquinone (t-BHQ), a well know Nrf2 inducer, stimulated a group of genes 
responsible for conferring protection against oxidative stress or inflammation in primary 
cortical astrocytes. The major functional categories are detoxification enzymes, antioxidant 
proteins, NADPH-producing proteins, growth factors, defense/immune/inflammation-
related proteins, and signaling proteins (Table 1). It has been proposed that proteins within 
these functional categories are vital to cell’s defense system, suggesting that an orchestrated 
change in the modulation of Nrf2/ARE pathway would stimulate a synergistic protective 
effect. 
Proteins and enzymes directly related with an antioxidant protective effect can be divided 
into 3 major groups (Lee et al., 2003a):  
Group 1. Genes involved in glutathione (GSH) homeostasis. GSTs catalyze the nucleophilic 
addition of GSH to an electrophilic group of a broad spectrum of xenobiotic compounds. 
GPx and PRx metabolize H2O2 to H2O and oxidized GSH (GSSG), and GR regenerates 
GSH. Ideally, in association with an increased utilization of GSH, there would also be an 
increased production of GSH. The rate-limiting step in the GSH biosynthesis is mediated 
by GCLM/GCLC. The coordinate regulation of these genes can evoke a synergistic effect 
in the maintenance of GSH levels, as well as in detoxification of reactive intermediates 
(Figure 5). 
Group 2. Genes involved in H2O2 detoxification and iron homeostasis. SOD and HO-1 are 
very important for cellular defense against oxidative stress. SOD detoxifies O2– resulting 
H2O2, and HO-1 generates a potent radical scavenger, bilirubin. However, SOD and HO-1 
can induce more oxidative stress because they increase the cellular concentrations of H2O2 
and free iron, respectively; which together can generate OH through the Fenton reaction. 
For complete detoxification of superoxide, H2O2 should be further metabolized to H2O by 
GPx, CAT, or PRx. CAT directly detoxifies H2O2, whereas PRx uses GSH (Figure 6) and/or 
thioredoxin (Trx) as an electron donor for peroxidation of H2O2, resulting in generation of 
GSSG or oxidized thioredoxin, respectively (Figure 6). GSSG and oxidized thioredoxin are 
converted to their reduced forms by GR and TXNRD1, respectively. In addition, proper 
management of free iron is also important for minimizing oxidative stress, and this can be 
best achieved by ferritin. Ferritin converts Fe2+ to Fe3+ (ferroxidase activity) and sequesters 
it, thereby avoiding the participation of Fe2+ in the Fenton reaction (Orino et al., 2001). Thus, 
up-regulation of HO-1 together with ferritin constitutes a physiological strategy to increase 
the antioxidant potential while OH formation is minimized. 
Group 3. Genes involved in NADPH homeostasis. NQO1, GR, and TXNRD1 are important in 
detoxifying quinones and maintaining the cellular redox balance. One common feature of 
these proteins is the fact that they use NADPH as an electron donor. So, for efficient 
detoxification and maintenance of cellular redox status, it would be beneficial to up-regulate 
these proteins together with the appropriate reducing potential (NADPH) to support 
enzymatic reactions. G6PD/malic enzyme can directly generate NADPH, and 
transketolase/transaldolase can increase NADPH production by regenerating substrates for 
G6PD (Figure 7). These Nrf2-dependent genes would also contribute to cell’s detoxification 
potential and cellular redox balance. 
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GENE GENE GENE 
Detoxification 
 NAD(P)H:quinone 
oxidoreductase-1 
(NQO1)a 
 Glutathione-S-
transferase (GST) A4a 
 GST Pi2a  
 GST Mu1a  
 GST Mu3a  
 GST Omega1a  
 GST microsomal-1a  
 UDP 
glycosyltransferase 
1A6a  
 Epoxide hydrolase-1a 
 Aldehyde 
dehydrogenase-2  
 Aldehyde 
dehydrogenase-9  
 Aldehyde oxidase-1  
 Cytochrome P450 1B1 
Signaling 
 Protein kinase, 
cAMP-dependent 
regulatory, type I┚ 
 AW125016 4 1.9 0.07 
NR 
 Mitogen-activated 
protein kinase-10  
 
Antioxidant/reducing 
potential 
 -glutamate cysteine 
ligase modifier 
subunit (GCLM)a  
 -glutamate cysteine 
ligase catalytic 
subunit (GCLC)a  
 Hemo oxygenase-1 
(HO-1) (decycling)a 
 Thioredoxin 
reductase-1 
(TXNRD-1)  
 Thioredoxin (Trx)a  
 Ferritin light chain-
1a  
 Ferritin H subunita  
 Type I 
peroxiredoxin (PRx)
 1-Cys PRx protein-2 
 Transferrin receptor 
 Cu, Zn superoxide 
dismutase 
(CuZnSOD)a  
 Catalase-1 (CAT)  
 Glutathione 
peroxidase-4 (GPx) 
 Glutathione 
reductase-1 (GR) 
 Glucose-6-
phosphate 
dehydrogenase (G-
6PD), X-linked  
 G-6PDH-2  
 Transaldolase-1  
 Transketolase  
 Solute carrier 
family-1/4  
 Glycine transporter-
 Malic enzyme, 
supernatanta  
Transcription
 CCAAT/enhancer-
binding protein-┚  
 Zinc finger protein 
of cerebellum-2  
 TG-interacting 
factor  
 MafG  
 Activating 
transcription factor-
4  
Growth  
 Proliferin  
 Proliferin-2  
 Nerve growth 
factor- ┚ 
 Platelet-derived 
growth factor-┙ 
Defense/immune/ 
inflammation 
 Macrophage C-type 
lectin  
 EST, similar to 
dithiolethione-
inducible-1  
 PAF acetylhydrolase 
 P lysozyme 
structural  
 Lysozyme M  
 Prostaglandin-
endoperoxide 
synthase-2  
 Matrix 
metalloproteinase-
12  
 
aKnown to contain or to potentially have an ARE sequence.  
Modified of Lee et al., 2003a. 
Table 1. Nrf2-dependent genes induced by tert-butylhydroquinone in primary cortical 
astrocytes 
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Fig. 5. Genes involved in glutathione (GSH) homeostasis are indicated in black boxes. GST, 
glutathione-S-transferase; GCLM, -glutamate cysteine ligase modifier subunit; GCLC,  
-glutamate cysteine ligase catalytic subunit; GPx, glutathione peroxidase; PRx, 
peroxiredoxin; GR, glutathione reductase.  
 
 
Fig. 6. Genes involved in H2O2 detoxification and iron homeostasis are indicated in black 
boxes. SOD, superoxide dismutase; CAT, catalase; PRx, peroxiredoxin; Trx, thioredoxin; 
HO-1, hemo oxygenase-1; TXNRD1, thioredoxin reductase-1. 
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Together, these coordinately regulated gene clusters presented in Figures 5, 6 and 7 strongly 
support the hypothesis that Nrf2-dependent gene expression is crucial for an efficient 
detoxification of reactive metabolites and ROS, as well as for the cellular capacity to 
counteract stressing events such as inflammation. 
 
 
Fig. 7. Genes involved in NADPH homeostasis are indicated in black boxes. P450, 
cytochrome P450; GST, glutathione-S-transferase; TXNRD1, thioredoxin reductase-1;  
NQO1, NAD(P)H:quinone oxidoreductase-1; GR, glutathione reductase; G6PD,  
glucose-6-phosphate dehydrogenase. 
6. Nrf2 characteristics 
The transcription factor Nrf2 (Nuclear factor-E2-related factor 2) is the guardian of redox 
homeostasis because it regulates basal and inducible expression of array ride of antioxidant 
and cytoprotective genes, providing a level of protection required for normal cellular 
activities and against various oxidative stress-related pathologies, including ischemic stroke 
(Cho & Kleeberger, 2009; Nguyen et al., 2004; Van Muiswinkel & Kuiperij, 2005). Nrf2 is 
highly expressed in detoxification organs - such as liver and kidney - and organs exposed to 
the external environment - such as skin, lung and digestive tract - (Motohashi et al., 2002), 
whereas in the brain its levels are low (Moi et al., 1994). 
Nrf2 is a member of the cap ‘n’ collar (CNC) family basic region-leucine zipper transcription 
factor (Katsuoka et al., 2005; Sykiotis & Bohmann, 2010). Nrf2 protein has six highly 
conserved regions, called Nrf2-ECH homology (Neh) domains. Neh1 is located in the half C-
terminal of the molecule and constitutes the basic DNA binding domain and the leucine 
zipper for dimerization. Neh2 domain is located in the proximal N-terminus of Nrf2 and 
represents the region through which Nrf2 associates with the cytoplasmic protein Keap1 
(kelch-like ECH-associated protein 1) (Itoh et al., 1999). Neh6 is a redox-insensitive degron, 
which is essential for maximal turnover of Nrf2 in stressed cells, as well as for its 
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degradation (McMahon et al., 2004). Neh3 domain is required for transcriptional activation 
of the protein (Nioi et al., 2005). Neh4 and Neh5 domains are required for its binding to ARE 
(Figure 8, upper panel). 
 
 
Fig. 8. Nrf2 and Keap1 domains. Upper panel: in Nrf2, Neh1 is the basic DNA binding 
domain and the leucine zipper for dimerization. Neh2 is the Keap1  
(kelch-like ECH-associated protein 1) binding domain. Neh3 is required for transcriptional 
activation of the protein. Neh4 and Neh5 domains are required for the binding to ARE. 
Neh6 is essential for both Nrf2 turnover in stressed cells and for its degradation.  
Lower panel: in Keap1, BTB domain functions as a substrate adaptor protein for a  
Cul3-dependent ubiquitin ligase complex. IVR domain is a domain of intervention which is 
distinguished for its high number of cysteine residues. DGR domain is associated with actin 
filaments, giving stability to Keap1. 
Under oxidant conditions, Nrf2 binds with high affinity to the cis-acting enhancer sequence 
called Antioxidant Response Element (ARE, 5´-GTGACnnnGC-3´), located in the 5´-flanking 
regions of a broad range of antioxidant and cytoprotective genes that act against 
oxidative/electrophilic damage (Nguyen et al., 2004; Rushmore et al., 1991). The binding of 
Nrf2 to ARE requires its heterodimerization with small Maf proteins (Katsuoka et al., 2005), 
which stimulates transcription of downstream genes, with participation of transcriptional 
co-activators - mainly CREB-binding protein (CBP) -, through the Neh4 and Neh5 domains 
(Figure 8, upper panel) in the transcription factor. These co-activators act synergistically to 
attain maximum its activity (Katoh et al., 2001).  
7. Regulation of Nrf2: Keap1 (ARE elements) 
Nrf2 activity is primarily regulated by suppressor protein Keap1 (Figure 8, lower panel), a 
member of the BTB (Broad complex/Tramtrack/Bric-a-brac)-Kelch protein family (Cullinan 
et al., 2004), that under normal conditions (unstressed) forms a complex with Nrf2 within 
the cytosol. This complex is associated with actin filaments through its double glycine repeat 
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(DGR) domain (Figure 10, left panel), which plays an important role in retention of Nrf2 
(Kang et al., 2004). 
BTB domain of Keap1 functions as an adaptor for Cul3-dependent E3 ubiquitin ligase 
complex that interacts with the seven lysine residues located in the Neh2 domain of Nrf2, 
promoting its ubiquitination (Kobayashi et al., 2004; Zhang et al., 2004) and its continuous 
degradation by 26S proteasome (Nguyen et al., 2003). This is supported by the relatively 
short half-life of Nrf2 (10-30 min) in absence of cellular stress (McMahon et al., 2003). Upon 
oxidative stress conditions, the interaction between Nrf2 and Keap1 is disrupted through 
changes in certain domains of Keap1, hence promoting the release of Nrf2 (Eggler et al., 
2005). 
The human Keap1 protein contains 27 cysteine residues, some of which are highly reactive 
to a wide variety of chemical stimuli. Furthermore, a large amount of evidence has emerged 
suggesting that certain cysteines of Keap1 may be targets of Nrf2 inducers such as 
sulforaphane, which reacts with thiol groups of Keap1 to form resistant thionoacyl adducts 
by hydrolysis and transacylation reactions (Hong et al., 2005) (Figure 9).  
 
 
Fig. 9. Formation of adducts between sulforaphane and Keap1. 
It has been reported that Cys151 in BTB domain of Keap1 is required for inhibition of 
Keap1-dependent Nrf2 degradation stimulated by sulforaphane and oxidative stress (Zhang 
& Hannink, 2003). Cys273 and Cys288, located in the IVR domain of Keap1, are essential for 
its repressive activity under basal conditions. It has been suggested that this effect also 
responds to sulforaphane (Kobayashi et al., 2006). On the other hand, it has been reported 
that Cys489, Cys583, and Cys624 were most reactive toward sulforaphane (Hong et al., 
2005). Therefore, the responsiveness of Nrf2 to inducers, such as sulforaphane, involves 
redox-dependent alterations of thiol groups in several domains of Keap1, which acts like a 
sensor responding to oxidative and environment stress through dynamic changes in cystein 
reducing status (Jung & Kwak, 2010). In turn, Keap1 is considered as a zinc metalloprotein 
because the chemical modification of critical cysteine residues is modulated by thiol-bound 
zinc (approximately 1 mol per subunit), which is displaced by the reaction with inducers or 
other classical sulfhydryl reagents, such as sulforaphane (Dinkova-Kostova et al., 2005b).  
Another important event in the activation of Nrf2 may be its phosphorylation. The protein 
kinase-dependent signal transduction pathways have been implicated in the release of Nrf2 
from Keap1-mediated repression, mainly by protein kinase C, whose target is a single serine 
residue, Ser40 (Bloom & Jaiswal, 2003; Huang et al., 2002). To explain how Keap1/Nrf2 
complex respond to basal or inducible stimuli, it has been proposed the “hinge and latch” 
model (Tong et al., 2006a), which suggests that a single Nrf2 molecule makes contacts with 
two domains of Keap1 homodimer (McMahon et al., 2006; Tong et al., 2006a). Neh2 domain 
of Nrf2 contains two sites for Keap1 binding, termed motifs DLG and ETGE. These motifs 
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exhibit different affinity for Keap1; the affinity of ETGE is greater than DLG (Tong et al., 
2006b). The term “hinge” indicates that the interaction of high affinity is not affected by 
inducers; in contrast, inducers abolish the low-affinity interaction mediated by the “latch”, 
thereby disrupting the presentation of Nrf2 to the ubiquitination machinery of Keap1 (Li & 
Kong, 2009) (Figure 10, right panel). Other models that describe the interaction between Nrf2 
and Keap1 have provided conflicting information when contrasted with the “hinge and 
latch” model (Lo & Hannink, 2006; 2008).  
 
 
Fig. 10. Effect of sulforaphane on Nrf2/Keap1 complex. Left panel: Upon unstressed 
conditions, this complex is dissociated and Nrf2 can either suffer proteosomal degradation 
or respond to stimuli typical of basal cell metabolism. In the later, Nrf2 is phosphorylated 
and translocated to the nucleus forming heterodimers with Maf and acting on ARE.  
Right panel: Under stress oxidative conditions, or in the presence of inducers, several 
cysteine residues suffer changes inducing its Nrf2 dissociation and further translocation of 
this factor to nucleus, where it will induce phase 2 genes transcription. 
Sulforaphane induces a phase 2 response as a result of gene expression modulation through 
Nrf2/ARE pathway. ARE-driven targets include NAD(P)H:quinone oxidereductase 
(NQO1), heme oxygenase-1 (HO-1) and -glutamylcysteine ligase (GCL). The induction of 
these enzymes has been observed both in in vivo and in vitro experiments after sulforaphane 
treatment. 
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8. Nrf2 in cerebral ischemia 
Nrf2 has been detected in neuronal and glial cells (Chen et al., 2011; Li et al., 2011; Shah et 
al., 2010; Yang et al., 2009). Previous studies using gel-shift assay found that ischemic brains 
selectively upregulates ARE-mediated gene expression, whereas binding activities of other 
stress response elements were unchanged, including metal response element, interleukin-6, 
and STAT (signal transducer and activator of transcription) response elements (Campage et 
al., 2000).  
Middle cerebral artery occlusion (permanent or transient) is a classical and well-
characterized model inducing cerebral ischemia in rats that involves a cytotoxic response 
occurring within few minutes from the onset of cerebral ischemia, and encompasses 
oxidative stress, pro-inflammatory responses and cell death (Ikeda et al., 2003; Longa et al., 
1989; Simonyi et al., 2005). Yang et al. (2009) used permanent focal ischemia to detect the 
expression of Nrf2. They found that Nrf2 protein and mRNA were upregulated when is 
compared with normal control, showing a peak at 24 h and localizing with nuclei and 
cytoplasm of neurons and astrocytes. Alternatively, Nrf2 was presented in the injured 
regions of cortices with cerebral ischemic/reperfusion, and markedly increased in both 
cytoplasm and nuclei (Li et al., 2011). Meanwhile, Keap1 immunoreactivity was significantly 
reduced. Besides, an altered expression of thioredoxin, glutathione, and heme oxigenase 
was detected (Tanaka et al., 2011). 
Oligemia is another model that was used to determine Nrf2 localization. It consists in a 
reduction in the mean arterial pressure to 30-40 mm Hg, resulting in a 50% reduction in 
cerebral blood flow after reperfusion. This blood flow reduction presents an increase in 
oxidative stress through lipid peroxidation (Heim et al., 1995; Läer et al., 1993) and an 
augmented OH production during the reperfusion phase (Heim et al., 2000). In this model, 
Nrf2 was specifically upregulated 1 h after the surgery. Nrf2-positive neurons were found in 
the Purkinje cells of the cerebellar cortex and in the pyramidal neurons of the cingulate 
cortex (Liverman et al., 2004). 
Additionally, Nrf2 knockout (Nrf2-/-) mice have been used to understand the role of Nrf2 
during ischemia-mediated oxidative brain insult.  
In vitro studies showed that neurons and astrocytes from Nrf2 knockout (Nrf2-/-) mice were 
more sensitive to oxidative stress, Ca2+ influx and mitochondrial toxicity than neurons and 
astrocytes from wild type animals; however, when the cells were transfected with a 
functional Nrf2 construct, they became less prone to oxidative stress (Kraft et al., 2004; Lee 
et al., 2003a; Lee and Johnson, 2004). Consistent with these results, dominant negative-Nrf2 
stable cells and Nrf2-sensitized neuroblastoma cells silenced with siRNA were more 
amenable to apoptosis induced by nitric oxide (Dhakshinamoorthy & Porter, 2004). Also, 
increasing Nrf2 activity in mixed neuronal/glial cultures was highly neuroprotective in in 
vitro models that simulated components of stroke damage, such as oxidative glutamate 
toxicity, H2O2 exposure, metabolic inhibition by rotenone, and Ca2+ overload (Duffy et al., 
1998; Kraft et al., 2004; Lee et al., 2003b; Murphy et al., 1991; Shih et al., 2003). 
In vivo, using permanent middle cerebral artery occlussion by cauterization, Shih et al. 
(2005) did not observe significant difference in infarct size between Nrf2-/- and Nrf2+/+ mice 
24 h after stroke. However, 7 days after permanent focal ischemia, they observed a two-fold 
increase in infarct volume with Nrf2-/- mice, while the infarct size of Nrf2 +/+ mice did not 
increase in size between 24 h and 7 days. On the other hand, Nrf2 knockout (Nrf2-/-) mice 
subjected to 90 min middle cerebral artery occlusion followed by 24 h reperfusion, showed 
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an infarct volume and neurological deficit significantly larger than in wild type mice (Shah 
et al., 2007). 
Taking together, these data suggest that Nrf2 is upregulated in permanent ischemia and 
ischemic/reperfusion, an augment that is related with a decreased expression of Keap1 and 
an altered expression of antioxidant proteins. Thus, this upregulation may be due to an 
alteration in the redox state, a mechanism through which cells active an antioxidant 
response to protect themselves from future oxidant damage. Moreover, it has been 
demonstrated that Nrf2 activation induces the expression of the Nrf2 gene itself (Lee et al., 
2005), indicating that the administration of Nrf2 inducers may be an important 
neuroprotective antioxidant mechanism that can limit stroke damage. 
9. Effect of Nrf2 inducers in cerebral ischemia 
A wide range of dietary phytochemicals or supplements with medicinal properties have 
been reported to activate adaptive stress responses related with the induction of 
cytoprotective genes through Nrf2 induction (Surh et al., 2008). The mechanism of action of 
such phytochemicals can therefore be considered as a form of hormesis where a stressor 
triggers an adaptive response which increases resistance to more severe stress and disease 
(Calabrese et al., 2007). Unfortunately, few of these compounds have been tested in brain 
ischemic models; some of them are sulforaphane, curcumin and ter-butilhydroquinone, 
among others.  
Sulforaphane 
Sulforaphane is a natural dietary isothiocyanate present in cruciferous vegetables of the 
genus Brassica such as broccoli, brussel sprouts, cauliflower, cabbage, etc. Several studies 
have shown the neuroprotective properties of sulforaphane against ischemia/reperfusion 
damage. It has been found that sulforaphane (5 mg/kg) reduced the cerebral infarct volume 
in a carotid/middle cerebral artery occlusion common model in rodents when it was 
administered 15 min after injury (Zhao et al., 2006). Other groups reported that an injection 
of sulforaphane (5 mg/kg) 30 min before the onset of ischemia reduced the infarct size in a 
neonatal hypoxia-ischemia model (Ping et al., 2010). In both studies, the protective effects of 
sulforaphane were associated with its well-known capacity to induce the expression of  
HO-1 mRNA and protein through Nrf2/ARE pathway.  
Other in vivo studies support the ability of sulforaphane as inducer of phase II enzymes in 
brain increasing HO-1, NQO1 and GST mRNA levels (Chen et al., 2011). It has also shown in 
in vitro studies that pretreatment and post-treatment with sulforaphane reduced 
hippocampal death of astrocytes and neurons induced by transient exposure to O2 and 
glucose deprivation. This protective effect was associated with nuclear accumulation of Nrf2 
accompanied by an increase in NQO1, HO-1 and GCL mRNA levels, and a decrease in DNA 
oxidation (Danilov et al., 2009; Soane et al., 2010). Altogether, these studies indicate that 
sulforaphane could be considered as a useful tool for pre- and post-treatment of brain injury 
due its well-know capacity as inducer of Nrf2.  
Curcumin 
Curcumin is a diferuloylmethane derived from the rhizomes of turmeric (Curcuma longa 
Linn, Zingiberaceae) widely used in Indian curry with a favorable safe profile. Its 
chemopreventive effects have been related with its antioxidant and anti-inflammatory 
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properties (Surh & Chun, 2007; Thangapazham et al., 2006). However, its mechanism of 
action is still poorly understood.  
Curcumin has a protective effect against neurodegeneration in cerebral ischemia through 
the preservation of the blood-brain barrier integrity, and a decrease of the ischemia-
induced lipid peroxidation, mitochondrial dysfunction and anti-apoptotic effects (Sun et 
al., 2008).  
Yang et al., (2009) observed that the systematic administration of curcumin (100 mg/kg) 
15 min after middle cerebral artery permanent occlusion increased Nrf2 nuclear 
translocation and Nrf2 and HO-1 gene and protein levels at 24 h onset of reperfusion. 
Curcumin reduced neurologic deficit, brain edema and infarct volume at 24 h after stroke. 
These results show that curcumin maybe an effective therapeutic drug for the treatment of 
brain injury toward a potential mechanism of upregulation Nrf2/ARE pathway at gene 
and protein levels.  
However, the bioavailability of curcumin is very limited due to poor absorption, rapid 
metabolism and quick systemic elimination. Moreover, it has a poor blood-brain barrier 
penetration following acute administration. To improve its bioavailability, pharmacokinetics 
and interaction with multiple viable targets, new curcumin derivatives are being 
synthesized (Lapchak, 2001). 
tert-Butylhydroquinone (t-BHQ) 
tert-butylhydroquinone (t-BHQ), a metabolite of the widely used food antioxidant butylated 
hydroxyanisole, has already been approved for human use (Food and Agriculture 
Organization of the United Nations/World Health Organization, 1999; National Toxicology 
Program, 1997). t-BHQ possesses an oxidizable 1,4 diphenolic structure that confers its 
potent ability to dissociate Keap1/Nrf2 complex (Van Ommen et al., 1992). T-BHQ can 
protect neuronal cells against the oxidative insult initiated by dopamine, H2O2, tert-butyl 
hydroperoxide, NMDA and glutamate (Duffy et al., 1998; Kraft et al., 2004; Li et al., 2002; 
Murphy et al., 1991; Shah et al., 2007).  
Shih et al., (2005) determined the neuroprotective effect of tBHQ in ischemic injury in two 
different ischemia/reperfusion models - middle cerebral artery occlusion and endothelin-1 
vasoconstriction - in rats and mice, using different routes of administration: 
intacerebroventricular, intraperitoneal, and dietary. Intracerebroventricular administration 
of t-BHQ (1 µL/h) during 3 days before rats were subjected to 1.5 h of ischemia and 24 h 
reperfusion showed a significant reduction of infarction in the cortex and a significant 
reduction in the neuronal scores. Intraperitoneal administration of t-BHQ (16.7 mg/Kg;  
3 times/8h) 24 h before middle cerebral artery occlusion improved functional recovery up to 
1 month after MCAO, showing a long-term benefit in ischemic damage and sensimotor 
deficit. Nrf2+/+ and Nrf2+/- mice fed with 1% t-BHQ during one week before permanent 
focal ischemia did not show changes in infarct area after 7 days, while Nrf2-/- mice were less 
tolerant to the diet, losing 20% body weight and showing a continuous growth of infarct 
area, thus suggesting that loss of Nrf2 function promotes peri-infact zone. Finally, Nrf2+/+ 
and Nrf2-/- mice were fed with t-BHQ after endothelin-1 administration into cortical 
parenchyma. Nrf2+/+ mice showed a decrease in endothelin-1-induced infarction while  
Nrf2-/- mice showed an exacerbated injury (Shih et al., 2003; 2005). 
Collectively, these data suggest that t-BHQ may have a therapeutic potential for ischemic 
injury by increasing brain antioxidant capacity though the up-regulation of Nrf2 expression.  
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10. Presumable protective effect of garlic compounds in cerebral ischemia 
Numerous studies have shown that garlic and its compounds exhibit a diverse biological 
activity, including anti-tumorigenic, anti-atherosclerosis, detoxification, anti-inflammatory, 
and antioxidant (Aguilera et al., 2010; Ali et al., 2000; Fisher et al., 2007; Fukushima et al., 
1997; Mathew & Biju, 2008). The effect of different garlic preparations (aged garlic extract, 
aqueous garlic extract, garlic oil) and isolated compounds (S-allylcysteine) in cerebral 
ischemia, has been associated to its ability to scavenge ROS, acting as direct antioxidants 
(Kim et al., 2006a).  
Gupta et al. (2003) found that garlic oil administration 90 min before the 
ischemia/reperfusion diminished the infarct area and associated this effect to its antioxidant 
properties. Saleem et al. (2006) showed that aqueous garlic extract treatment increased 
neurobehavioral score, decreased malondialdehyde levels, increased GSH content, and 
prevented the depletion in GPx, GR, GST and Na+/K+-ATPasa activities. Moreover, CAT 
and SOD activities were increased by aqueous garlic extract. Aguilera et al. (2010) reported 
that the major protective effect exerted by aged garlic extract was observed when it was 
administered at the onset of reperfusion. In this work, aged garlic extract prevented the 
ischemia/reperfusion-induced increase in nitrotyrosine levels and the decrease in GPx, SOD 
and CAT activities both in cortex and striatum.  
Numagami et al. (1996) demonstrated that aged garlic extract compounds that present a 
thioallyl group (particularly S-allylcysteine) exhibited a strong antioxidant capacity in a 
model of cerebral ischemia in rats. Indeed, S-allylcysteine reduced the infarct volume and 
brain edema, while prevented ONOO– formation and lipid peroxidation (Numagami & 
Ohnishi, 2001). More recently, S-allylcysteine (300 mg/kg, i.p.) produced a protective effect 
on cerebral ischemic injury in rats due to the inhibition of extracellular signal-regulated 
kinase activity (Kim et al., 2006a). The fact that S-allylcysteine can cross the blood-brain 
barrier turned it soon of potential interest to be tested in neurotoxic models. In fact, the 
prophylactic impact and rescue properties of S-allylcysteine in ischemia/reperfusion injury 
are being recently discussed and reinforced (Sener et al., 2007). In addition, S-allylcysteine is 
a stable compound (Lawson, 1998) and is easily absorbed by gastrointestinal tract after oral 
administration (Kodera et al., 2002). One of its advantages in regard to other garlic 
compounds, such as allicin and dialyl sulfide, is its limited toxicity established by its higher 
lethal oral dose (Amagase et al., 2001). Pharmacokinetic studies demonstrate fast absorption 
and distribution phases followed by a slow elimination phase for oral administration, as 
well as fast distribution and slow elimination phases for i.v. administration (Nagae et al., 
1994; Yan & Zeng, 2005). Pharmacokinetics of S-allylcysteine in humans by oral garlic 
administration revealed a half-life of 10 h and clearance time of 30 h (Kodera et al., 2002), 
suggesting a high bioavailability. After its oral administration, S-allylcysteine is absorbed by 
gastrointestinal tract, and its higher concentrations are detected in plasma and kidney up to 
8 h post-intake (Nagae et al., 1994; Yan & Zeng, 2005). 
On the other hand, garlic oil-derived organosulfur compounds such as diallyl trisulfide, 
dialyl disulfide, and dialyl sulfide provide significant protection against carcinogenesis, and 
this protection is likely related with their antioxidant properties (Maldonado et al., 2009). 
Moreover, the lipophilic characteristics of these compounds allow crossing the blood-brain 
barrier as follows: dialyl sulfide crosses the blood-brain barrier easier than dialyl disulfide > 
diallyl trisulfide > S-allylcysteine (Kim et al., 2006b). 
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Recently, it has been reported that some garlic compounds (diallyl trisulfide, dialyl 
disulfide, dialyl sulfide and S-ally-L-cysteine) are able to activate Nrf2 factor in liver, 
kidney, intestine and lung. (Chen et al., 2004; Fisher et al., 2007; Fukao et al., 2004; Gong et 
al., 2004; Guyonnet et al., 1999; Kalayarasan et al., 2008; 2009; Wu et al., 2002). However, 
there is no information on Nrf2 induction by these garlic compounds in the brain. 
Altogether, these data indicate that S-ally-L-cysteine, diallyl trisulfide, dialyl disulfide, and 
dialyl sulfide may be alternative treatments for cerebral ischemia through Nrf2 
upregulation. 
11. Conclusion  
Nowadays is widely recognized that up-regulation of phase 2 response is a powerful, highly 
efficient and promising antioxidant strategy for protection against several diseases, 
including ischemic stroke. A wide range of dietary phytochemicals with medicinal 
properties have been reported to activate adaptive stress responses related with the 
induction of cytoprotective genes through Nrf2/ARE pathway. Unfortunately, few of these 
compounds (sulforaphane, curcumin, ter-butilhydroquinone) have been tested in cerebral 
ischemia experimental models. Moreover, these compounds have characteristics that limit 
their use as therapeutic agents in ischemic stroke. For example, sulforaphane is expensive, 
while curcumin poorly crosses the blood-brain barrier. Due to this, new agents should be 
evaluated. In this context, some garlic compounds (diallyl sulfide, diallyl disulfide, diallyl 
trisulfide and S-allylcysteine) could be promising agents for treatment of ischemic stroke 
because their physicochemical properties are promising, their absorption is high and most 
of them can easily cross the blood-brain barrier. Moreover, they have the ability to active 
Nrf2 factor and induce a phase 2 response in several models of hepatic and renal damage.  
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13. Abbreviation list  
ARE   Antioxidant Response Element 
BH2   Dihydrobiopterin 
BH4   Tetrahydrobiopterin 
CAT   Catalase 
G6PD   Glucose-6phosphate dehydrogenase 
GCLC   Glutamate cysteine ligase catalitic subunit 
GCLM   Glutamate cysteine ligase modifier subunit 
GPx   Glutathione Peroxidase 
GSH   Reduced Glutathione  
GSSG   Oxidized Glutathione 
HO-1   Heme oxygenase-1 
NQO1   NADPH:quinone oxidoreductase-1 
Keap1   Kelch-like ECH-associated protein 1 
Nrf2   Nuclear Factor-E2-related Factor 2 
RNS   Reactive Nitrogen Species 
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ROS   Reactive Oxygen Species 
SOD   Superoxide Dismutase 
tBHQ   tert-butylhydroquinone 
TXNRD1  Thioredoxine Reductase-1 
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